StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)

Close on Nov 17, 2026Market cap $136.07MP/E –Yield –

Burning Rock Biotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Burning Rock Biotech's price to sales ratio was 12.7× on Jan 29, 2021.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Jan 29, 202112.7×+2.8
2020Dec 31, 20209.9×–

More Burning Rock Biotech figures

See a number that looks wrong?